Exploiting personalized information for reagent selection in drug design

Drug Discovery Today

Volumn 16, Issue 5-6, 2011, Pages 181-187

  Boström, Jonas ^a   Falk, Niklas ^a   Tyrchan, Christian ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANILINE; ATORVASTATIN; CHLORPROMAZINE; IMIPRAMINE; REAGENT; SILDENAFIL;

AMES TEST; CHEMICAL ANALYSIS; DATA BASE; DRUG DESIGN; DRUG INDUSTRY; DRUG SCREENING; GENOTOXICITY; HUMAN; REVIEW;

EID: 79952452599     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2011.01.006     Document Type: Short Survey

References (35)

1. S. Andersson Making medicinal chemistry more effective: application of lean sigma to improve processes, speed and quality Drug Discov. Today 14 2009 598 604
2. E. Petrillo Lean thinking for drug discovery - better productivity for pharma Drug Discov. World 8 2007 9 16
3. C. Lipinski Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 23 1997 3 25 (Pubitemid 27046991)
4. C. Lipinski Drug-like properties and the causes of poor solubility and poor permeability J. Pharmacol. Toxicol. Methods 44 2000 235 249 (Pubitemid 32239479)
5. C. Lipinski, and A. Hopkins Navigating chemical space for biology and medicine Nature 432 2004 855 861 (Pubitemid 40037141)
6. M.C. Wenlock A comparison of physiochemical property profiles of development and marketed oral drugs J. Med. Chem. 46 2003 1250 1256 (Pubitemid 36428230)
7. D.F. Veber Molecular properties that influence the oral bioavailability of drug candidates J. Med. Chem. 45 2002 2615 2623 (Pubitemid 34595232)
8. T.W. Johnson Using the golden triangle to optimize clearance and oral absorption Bioorg. Med. Chem. Lett. 19 2009 5560 5564
9. P.D. Leeson, and B. Springthorpe The influence of drug-like concepts on decision-making in medicinal chemistry Nat. Rev. Drug Discov. 6 2007 881 890 (Pubitemid 350042396)
10. A.R. Leach Fragment screening: an introduction Mol. Biosyst. 2 2006 430 446 (Pubitemid 44267725)
11. J. Kelder Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs Pharm. Res. 16 1999 1514 1519 (Pubitemid 29510546)
12. S.K. Bhal The rule of five revisited: applying log D in place of log P in drug-likeness filters Mol. Pharm. 4 2007 556 560 (Pubitemid 47310166)
13. M.J. Waring Defining optimum lipophilicity and molecular weight ranges for drug candidates; molecular weight dependent lower log D limits based on permeability Bioorg. Med. Chem. Lett. 19 2009 2844 2851
14. F. Lovering Escape from flatland: increasing saturation as an approach to improving clinical success J. Med. Chem. 52 2009 6752 6756
15. T.J. Ritchie, and S.J. Macdonald The impact of aromatic ring count on compound developability: are too many aromatic rings a liability in drug design? Drug Discov. Today 14 2009 1011 1020
16. M.J. Waring, and C. Johnstone A quantitative assessment of hERG liability as a function of lipophilicity Bioorg. Med. Chem. Lett. 17 2007 1759 1764
17. J.D. Hughes Physiochemical drug properties associated with in vivo toxicological outcomes Bioorg. Med. Chem. Lett. 18 2008 4872 4875
18. M.P. Gleeson Generation of a set of simple, interpretable ADMET rules of thumb J. Med. Chem. 51 2008 817 834 (Pubitemid 351304691)
19. M.Q. Zhang, and B. Wilkinson Drug discovery beyond the 'rule-of-five' Curr. Opin. Biotechnol. 18 2007 478 488
20. M.S. Lajiness Molecular properties that influence oral drug-like behavior Curr. Opin. Drug Discov. Dev. 7 2004 470 477 (Pubitemid 44383553)
21. W.A. Ray Atypical antipsychotic drugs and the risk of sudden cardiac death N. Engl. J. Med. 360 2009 225 235
22. H. Kubinyi Chance favors the prepared mind. From serendipity to rational drug design J. Recept. Signal Transduct. Res. 19 1999 15 39 (Pubitemid 29152173)
23. T.A. Ban The role of serendipity in drug discovery Dialogues Clin. Neurosci. 8 2006 335 344 (Pubitemid 44682750)
24. N.K. Terrett Sildenafil (VIAGRA™), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction Bioorg. Med. Chem. Lett. 6 1996 1819 1824 (Pubitemid 26253884)
25. G. Adomavicius, and A. Tuzhilin Toward the next generation of recommender systems: a survey of the state-of-the-art and possible extensions IEEE Trans. Knowl. Data Eng. 17 2005 734 749 (Pubitemid 40860454)
26. G. Linden Amazon.com recommendations: item-to-item collaborative filtering IEEE Internet Comput. 7 2003 76 80
27. D. Goldberg Using collaborative filtering to weave an information tapestry Commun. ACM 35 1992 61 70
28. W.D. Hamilton Geometry for the selfish herd Theor. Biol. 31 1971 295 311
29. K. Mortelmans, and E. Zeiger The Ames Salmonella/microsome mutagenicity assay Mutat. Res. 455 2000 29 60
30. B.N. Ames An improved bacterial test system for the detection and classification of mutagens and carcinogens Proc. Natl. Acad. Sci. U.S.A. 70 1973 782 786
31. D. Rogers, and M. Hahn Extended-connectivity fingerprints J. Chem. Inf. Model. 50 2010 742 754
32. J.L. Durant Reoptimization of MDL keys for use in drug discovery J. Chem. Inf. Comp. Sci. 42 2003 1273 1280
33. S.W. Muchmore Cheminformatic tools for medicinal chemists J. Med. Chem. 53 2010 4830 4841
34. V. Shanmugasundaram Hit-directed nearest-neighbor searching J. Med. Chem. 48 2005 240 248 (Pubitemid 40105262)
35. R.P. Sheridan, and S.K. Kearsley Why do we need so many chemical similarity search methods? Drug Discov. Today 7 2002 903 911